A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)

Stopped Edwards acquired CardiAQ and opted to terminate this study. 2 patients were enrolled and follow-up is complete. No further enrollment or follow-up will occur.

Conditions

• Mitral Insufficiency
• Heart Valve Disease
• Cardiovascular Disease
• Heart Disease

Interventions

• DEVICE: CardiAQ TMVI System (Transapical DS)

Sponsor

Edwards Lifesciences